Genetic Susceptibility to Acute Viral Bronchiolitis
The Journal of Infectious Diseases · 14.08.2025 · 232 (2) · e193-e202
DOI: 10.1093/infdis/jiae467 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 20.09.2024. Verfasst von Anu Pasanen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Clinical Medicine, University of Oulu. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Bronchiolitis, Viral, Cadherins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Alma och K.A. Snellman Säätiö, Sigrid Jusélius Foundation, Foundation for Pediatric Research.
Abstract (Originalsprache)
Background
Acute viral bronchiolitis is a major cause of infant hospitalizations worldwide. Childhood bronchiolitis is considered a risk factor for asthma, suggesting shared genetic factors and biological pathways. Genetic risk loci may provide new insights into disease pathogenesis.
Methods
We conducted a genome-wide association study to examine the genetic contributions to bronchiolitis susceptibility in the FinnGen project data. We analyzed 1465 infants hospitalized for bronchiolitis who were <2 years of age and 356 404 individuals without a history of acute lower respiratory infections.
Results
The genome-wide association study identified associations (P < 5 × 10−8) for variants in gasdermin B (GSDMB) and a missense variant in cadherin-related family member 3 (CDHR3). Children with bronchiolitis in infancy were more likely to develop asthma later in life as compared with controls. The 2 associated loci were previously linked to asthma and susceptibility to wheezing illness by causative agents other than respiratory syncytial virus (RSV). The identified loci were associated with overall bronchiolitis, with larger effects in non-RSV than RSV-induced infection.
Conclusions
Our results suggest that genetic variants in CDHR3 and GSDMB modulate susceptibility to bronchiolitis, especially when caused by viruses other than RSV. Severe bronchiolitis in infancy may trigger the development of asthma in genetically susceptible individuals, or it could be a marker of genetic predisposition to asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit of Clinical Medicine, University of Oulu.
- Medical Research Center Oulu, Oulu University Hospital and University of Oulu.
- Department of Children and Adolescents, Oulu University Hospital.
- Research Unit of Population Health, Faculty of Medicine, University of Oulu.
- Child Health Research Center, Tampere University and University Hospital.
- Faculty of Medicine and Health Technology, Tampere University, Finland.
ORCID-Profile: Anu Pasanen
Förderung
- Stiftelsen Alma och K.A. Snellman Säätiö
- Sigrid Jusélius Foundation
- Foundation for Pediatric Research
- Business Finland
- AbbVie Inc
- AstraZeneca UK Limited
- Biogen MA Inc
- Bristol-Myers Squibb
Zitieren
APA
Pasanen, A., Karjalainen, M. K., Korppi, M., Hallman, M., Rämet, M., & Research Project FinnGen (2025). Genetic Susceptibility to Acute Viral Bronchiolitis. The Journal of Infectious Diseases, 232(2), e193-e202. https://doi.org/10.1093/infdis/jiae467
Vancouver
Pasanen A, Karjalainen MK, Korppi M, Hallman M, Rämet M, Research Project FinnGen. Genetic Susceptibility to Acute Viral Bronchiolitis. The Journal of Infectious Diseases. 2025;232(2):e193-e202. doi:10.1093/infdis/jiae467
BibTeX
@article{Pasanen2025,
author = {Pasanen, Anu and Karjalainen, Minna K and Korppi, Matti and Hallman, Mikko and Rämet, Mika and Research Project FinnGen, Research Project FinnGen},
title = {Genetic Susceptibility to Acute Viral Bronchiolitis},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {2},
pages = {e193--e202},
doi = {10.1093/infdis/jiae467}
}
EUVIMED